Sponsor of the Day:
Jerkmate
https://juvlabs.com/our-pipeline/
Our Pipeline - Juvenescence
Jan 16, 2025 - CORE MEDICINES PIPELINE Leading Healthspan Innovations Our core medicines (JuvTherapeutics) are comprised of therapeutics developed by the Juvenescence team,...
pipelinejuvenescence
https://www.amherstindy.org/tag/juvenescence/
Juvenescence - Amherst Indy
amherst indyjuvenescence
https://juvlabs.com/science/
Science - Juvenescence
Oct 1, 2024 - SCIENTIFIC APPROACH What Causes Aging? We base our work on breakthrough scientific discoveries that target the underlying biological causes of aging. 85% of...
sciencejuvenescence
https://juvlabs.com/our-team/jim-mellon/
Jim Mellon - Juvenescence
Oct 9, 2024 - Jim MellonDeputy Chairman / Co-Founder Jim Mellon, a co-founder and Deputy Chairman of Juvenescence, was inspired by the possibilities and advances being made...
jimmellonjuvenescence
https://juvlabs.com/
Biotech Company - Juvenescence
Jan 6, 2026 - We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
biotech companyjuvenescence
https://juvlabs.com/news/
News - Juvenescence
Oct 1, 2024 - In the News Press Releases All
newsjuvenescence
https://juvlabs.com/news/press-releases/juvenescence-completes-phase-1-trial-of-pai-1-inhibitor/
Juvenescence Completes Phase 1 Trial of PAI-1 Inhibitor - Juvenescence
Feb 26, 2026 - Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership PAI-1 Inhibitor (MDI-2517)...
phase 1juvenescencecompletestrialpai